KALIDEX PHARMACEUTICALS, INC. — Form D
KALIDEX PHARMACEUTICALS, INC. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2011-03-09. The offering totals $45.0M, of which $8.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-03-09
- Form: D
- Accession: 0001505215-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $45.0M
- Amount sold: $8.2M
- Remaining: $36.7M
- Investors: 8
- Date of first sale: 2011-03-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-156449
Issuer
- Name: KALIDEX PHARMACEUTICALS, INC.
- CIK: 0001505215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 70 WILLOW ROAD, MENLO PARK, CA, 94025
- Phone: 650-325-5156
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Brent Vernon Ahrens | Director | Menlo Park, CA |
| Shelley Vernon Chu | Director | Menlo Park, CA |
| Yigong James Ge | Director | Menlo Park, CA |
| Patrick Vernon Heron | Director | Menlo Park, CA |
| Ron Vernon Hunt | Director | Menlo Park, CA |
| Gary Vernon Patou | Director | Menlo Park, CA |
| Dennis Vernon Podlesak | Director | Menlo Park, CA |
| Yigong James Ge | Executive Officer | Menlo Park, CA |
| Chun Vernon Jiang | Executive Officer | Menlo Park, CA |
Other filings by this issuer (1)
More